Click Therapeutics

About:

Click Therapeutics delivers safe and effective digital treatments to patients in need.

Website: http://www.clicktherapeutics.com

Twitter/X: click_tx

Top Investors: Accelmed, Silicon Valley Bank, Revelation Partners, HSBC Innovation Banking, Health Catalyst Capital

Description:

Click Therapeutics develops and commercializes software as medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults.

Total Funding Amount:

$946M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New York, New York, United States

Founded Date:

2012-04-01

Contact Email:

Info(AT)clicktherapeutics.com

Founders:

Bruce Leuchter, David Benshoof Klein, Victor Gao

Number of Employees:

101-250

Last Funding Date:

2023-11-06

IPO Status:

Private

© 2025 bioDAO.ai